2m 2m 2m 2m 2m 2m 2m
Incyte (INCY)
NASDAQ
$104.42+$0.76 (+0.73%)
Price as of Jun 23, 2026 5:52 PM EDT- $20.7BMarket Cap
- 54.12%1-Year Change
- BiotechnologyIndustry
Incyte (INCY)
$104.42+$0.76 (+0.73%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.4B +2.67% | 4.2B +14.76% | 3.7B +8.87% | 3.4B +13.67% | |
Cost of Revenue | 372.1M +19.25% | 312.1M +22.38% | 255.0M +23.19% | 207.0M +37.09% | |
Gross Profit | 4.0B +1.35% | 3.9B +14.20% | 3.4B +7.94% | 3.2B +12.43% | |
Sales and Marketing Expense | 1.4B +10.79% | 1.2B +6.96% | 1.2B +15.88% | 1.0B +35.50% | |
Research and Development Expense | -2.1B -21.36% | -2.6B +60.17% | -1.6B +2.63% | -1.6B +8.76% | |
Depreciation and Amortization Expense | 93.3M +4.52% | 89.2M +7.97% | 82.7M +21.82% | 67.9M +17.31% | |
Total Operating Expenses | 3.6B -13.24% | 4.2B +35.92% | 3.1B +9.23% | 2.8B +17.28% | |
Operating Profit | 1.5B +2,368.56% | 61.4M -90.11% | 620.5M +7.09% | 579.4M -1.08% | |
Interest Income | 105.6M -17.96% | 128.7M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -2.6M -4.31% | -2.7M +39.73% | |
Interest Income and Expense and Net | 105.6M -17.96% | 128.7M +5,145.47% | -2.6M -4.31% | -2.7M +39.73% | |
Total Nonoperating Income and Expense | 25.1M +96.03% | 12.8M -92.57% | 172.3M +331.60% | 39.9M +275.05% | |
Income before Taxes | 1.7B +425.68% | 316.6M -62.04% | 834.2M +57.66% | 529.1M -7.24% | |
Income Taxes | 377.8M +33.02% | 284.0M +20.03% | 236.6M +25.56% | 188.5M +149.84% | |
Extraordinary Items | 76.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 1.3B +3,844.96% | 32.6M -94.54% | 597.6M +75.42% | 340.7M -64.09% | |
Net Income from Continuing Operations Applicable to Common | 1.7B +425.68% | 316.6M -62.04% | 834.2M +57.66% | 529.1M -7.24% | |
Basic EPS and Net Income | 6.59 +4,018.75% | 0.16 -94.01% | 2.67 +74.51% | 1.53 -64.42% | |
Diluted EPS and Net Income | 6.41 +4,173.33% | 0.15 -94.34% | 2.65 +74.34% | 1.52 -64.40% | |
Basic Weighted Average Shares | 195.2M -5.75% | 207.1M -7.39% | 223.6M +0.73% | 222.0M +0.71% | |
Diluted Weighted Average Shares | 200.7M -4.67% | 210.5M -6.82% | 225.9M +0.88% | 224.0M +0.85% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.1B +83.54% | 1.7B -47.47% | 3.2B +8.88% | 3.0B +43.45% | |
Short-Term Investments | N/A N/A | N/A N/A | 442.7M +53.95% | 287.5M -1.10% | |
Cash and Cash Equivalents and Short-Term Investments | 3.1B +83.54% | 1.7B -53.83% | 3.7B +12.88% | 3.2B +37.93% | |
Total Current Assets | 5.0B +55.11% | 3.2B -30.27% | 4.6B +13.50% | 4.1B +31.24% | |
Accumulated Depreciation | 375.1M +14.35% | 328.0M +21.51% | 269.9M +26.84% | 212.8M +21.11% | |
Property and Plant and Equipment and Net | 730.9M -4.26% | 763.4M +1.58% | 751.5M +1.65% | 739.3M +2.13% | |
Total Long-Term Assets | 18.2M +67.46% | 10.8M -79.18% | 52.1M +104.86% | 25.4M -31.82% | |
Total Assets | 7.0B +27.80% | 5.4B -19.73% | 6.8B +16.11% | 5.8B +18.40% | |
Income Taxes Payable | 4.8M -80.01% | 23.8M -43.77% | 42.3M N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.5B -7.72% | 1.6B +32.37% | 1.2B +7.20% | 1.2B +35.44% | |
Total Long-Term Debt | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Total Long-Term Liabilities | 165.3M -1.36% | 167.5M +12.33% | 149.2M +50.29% | 99.2M +40.94% | |
Total Liabilities | 1.8B -10.33% | 2.0B +25.40% | 1.6B +8.25% | 1.5B +26.43% | |
Retained Earnings | 213.8M +119.92% | -1.1B -768.94% | 160.4M +136.68% | -437.2M -43.79% | |
Total Stockholders Equity | 5.2B +49.89% | 3.4B -33.57% | 5.2B +18.76% | 4.4B +15.92% | |
Total Shares Outstanding | 198.5M +2.60% | 193.4M -13.76% | 224.3M +0.69% | 222.7M +0.75% | |
Cash Flow | |||||
Cash from Operating Activities | 1.4B +321.52% | 335.3M -32.46% | 496.5M -48.81% | 969.9M +29.41% | |
Capital Expenditures | N/A N/A | N/A N/A | 32.5M -58.26% | 77.8M -57.00% | |
Cash from Investing Activities | -102.6M -165.14% | 157.5M +175.85% | -207.7M +164.42% | -78.5M -62.18% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 101.0M +105.00% | -2.0B +9,991.08% | -20.0M +2,423.05% | -794,000 -112.86% | |
Financials Ratio | |||||
Gross Margin | 91.45% -1.28% | 92.64% -0.49% | 93.10% -0.85% | 93.90% -1.10% | |
Operating Margin | 34.79% +2,304.43% | 1.45% -91.38% | 16.79% -1.63% | 17.07% -12.98% | |
Return on Assets | 20.75% +3,789.15% | 0.53% -94.37% | 9.47% +49.73% | 6.32% -71.69% | |
Return on Equity | 29.87% +3,855.19% | 0.76% -93.96% | 12.50% +49.37% | 8.37% -71.85% | |
Revenue Growth | 2.67% -81.93% | 14.76% +66.48% | 8.87% -35.16% | 13.67% +14.11% | |
Current Ratio | 3.32 +68.07% | 1.97 -47.32% | 3.75 +5.88% | 3.54 -3.10% | |
Cash Ratio | 2.04 +98.88% | 1.03 -60.32% | 2.59 +1.56% | 2.55 +5.92% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow